Quarterly report · Q2
2927.TEDINET S100T9RA
Period2023-09-01 → 2024-02-29
Filed2024-04-15
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 50
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥14.5bn | 2023-09-01 → 2024-02-29 | Cons. | Net sales |
| Revenue | ¥25.6bn | 2022-09-01 → 2023-08-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥12.4bn | 2022-09-01 → 2023-02-28 | Cons. | Net sales |
| Operating income | ¥1.0bn | 2023-09-01 → 2024-02-29 | Cons. | Operating income |
| Operating income | ¥678m | 2022-09-01 → 2023-02-28 | Cons. | Operating income |
| Ordinary income | ¥1.1bn | 2023-09-01 → 2024-02-29 | Cons. | Ordinary income |
| Ordinary income | ¥1.1bn | 2023-09-01 → 2024-02-29 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.7bn | 2022-09-01 → 2023-08-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥708m | 2022-09-01 → 2023-02-28 | Cons. | Ordinary income |
| Profit before tax | ¥1.0bn | 2023-09-01 → 2024-02-29 | Cons. | Income before income taxes |
| Profit before tax | ¥616m | 2022-09-01 → 2023-02-28 | Cons. | Income before income taxes |
| Net income (owners) | ¥642m | 2023-09-01 → 2024-02-29 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥1.1bn | 2022-09-01 → 2023-08-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥414m | 2022-09-01 → 2023-02-28 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥642m | 2023-09-01 → 2024-02-29 | Cons. | Profit loss |
| Net income | ¥417m | 2022-09-01 → 2023-02-28 | Cons. | Profit loss |
| Total assets | ¥44.3bn | at 2024-02-29 | Cons. | Assets |
| Total assets | ¥41.1bn | at 2023-08-31 | Cons. | Assets |
| Total assets | ¥39.0bn | at 2023-02-28 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥30.7bn | at 2024-02-29 | Cons. | Liabilities |
| Total liabilities | ¥27.9bn | at 2023-08-31 | Cons. | Liabilities |
| Net assets / equity | ¥13.6bn | at 2024-02-29 | Cons. | Net assets |
| Net assets / equity | ¥13.2bn | at 2023-08-31 | Cons. | Net assets |
| Net assets / equity | ¥12.6bn | at 2023-02-28 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥10.3bn | at 2024-02-29 | Cons. | Cash and deposits |
| Cash and deposits | ¥11.2bn | at 2023-08-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥10.2bn | at 2024-02-29 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥11.1bn | at 2023-08-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥10.8bn | at 2023-02-28 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥10.3bn | at 2022-08-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | −¥265m | 2023-09-01 → 2024-02-29 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥865m | 2022-09-01 → 2023-08-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥397m | 2022-09-01 → 2023-02-28 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥1.4bn | 2023-09-01 → 2024-02-29 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥1.9bn | 2022-09-01 → 2023-08-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥791m | 2022-09-01 → 2023-02-28 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | ¥708m | 2023-09-01 → 2024-02-29 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥1.9bn | 2022-09-01 → 2023-08-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥924m | 2022-09-01 → 2023-02-28 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥45.79 | 2023-09-01 → 2024-02-29 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥22.99 | 2023-12-01 → 2024-02-29d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥78.51 | 2022-09-01 → 2023-08-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥29.46 | 2022-09-01 → 2023-02-28 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥18.01 | 2022-12-01 → 2023-02-28d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥45.74 | 2023-09-01 → 2024-02-29 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥78.46 | 2022-09-01 → 2023-08-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥29.45 | 2022-09-01 → 2023-02-28 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 30.7% | at 2024-02-29 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 31.9% | at 2023-08-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 32.3% | at 2023-02-28 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 45
| Segment | Item | Period | Value |
|---|---|---|---|
| Otherother segments | revenue | 2023-09-01 → 2024-02-29 | ¥1.0bn |
| Otherother segments | revenue external | 2023-09-01 → 2024-02-29 | ¥1.0bn |
| Otherother segments | revenue intersegment | 2023-09-01 → 2024-02-29 | ¥10m |
| Otherother segments | segment profit | 2023-09-01 → 2024-02-29 | −¥167m |
| Reconciling Itemsreconciling | revenue | 2023-09-01 → 2024-02-29 | −¥54m |
| Reconciling Itemsreconciling | revenue intersegment | 2023-09-01 → 2024-02-29 | −¥54m |
| Reconciling Itemsreconciling | segment profit | 2023-09-01 → 2024-02-29 | −¥335m |
| jpcrp040300-q2r_E01064-000Department Store Businessreportable segment | revenue | 2023-09-01 → 2024-02-29 | ¥2.6bn |
| jpcrp040300-q2r_E01064-000Department Store Businessreportable segment | revenue external | 2023-09-01 → 2024-02-29 | ¥2.6bn |
| jpcrp040300-q2r_E01064-000Department Store Businessreportable segment | revenue intersegment | 2023-09-01 → 2024-02-29 | ¥2m |
| jpcrp040300-q2r_E01064-000Department Store Businessreportable segment | segment profit | 2023-09-01 → 2024-02-29 | ¥41m |
| jpcrp040300-q2r_E01064-000Food Service Businessreportable segment | revenue | 2023-09-01 → 2024-02-29 | ¥1.0bn |
| jpcrp040300-q2r_E01064-000Food Service Businessreportable segment | revenue external | 2023-09-01 → 2024-02-29 | ¥1.0bn |
| jpcrp040300-q2r_E01064-000Food Service Businessreportable segment | revenue intersegment | 2023-09-01 → 2024-02-29 | ¥5m |
| jpcrp040300-q2r_E01064-000Food Service Businessreportable segment | segment profit | 2023-09-01 → 2024-02-29 | −¥2m |
| jpcrp040300-q2r_E01064-000Health Carereportable segment | revenue | 2023-09-01 → 2024-02-29 | ¥8.8bn |
| jpcrp040300-q2r_E01064-000Health Carereportable segment | revenue external | 2023-09-01 → 2024-02-29 | ¥8.8bn |
| jpcrp040300-q2r_E01064-000Health Carereportable segment | revenue intersegment | 2023-09-01 → 2024-02-29 | ¥36m |
| jpcrp040300-q2r_E01064-000Health Carereportable segment | segment profit | 2023-09-01 → 2024-02-29 | ¥1.4bn |
| jpcrp040300-q2r_E01064-000Medical Productsreportable segment | revenue | 2023-09-01 → 2024-02-29 | ¥1.1bn |
| jpcrp040300-q2r_E01064-000Medical Productsreportable segment | revenue external | 2023-09-01 → 2024-02-29 | ¥1.1bn |
| jpcrp040300-q2r_E01064-000Medical Productsreportable segment | segment profit | 2023-09-01 → 2024-02-29 | ¥86m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-09-01 → 2024-02-29 | ¥14.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-09-01 → 2024-02-29 | ¥14.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2023-09-01 → 2024-02-29 | ¥54m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-09-01 → 2024-02-29 | ¥1.4bn |
| Otherother segments | revenue | 2022-09-01 → 2023-02-28 | ¥540m |
| Otherother segments | revenue external | 2022-09-01 → 2023-02-28 | ¥540m |
| Otherother segments | segment profit | 2022-09-01 → 2023-02-28 | −¥2m |
| Reconciling Itemsreconciling | segment profit | 2022-09-01 → 2023-02-28 | −¥255m |
| jpcrp040300-q2r_E01064-000Department Store Businessreportable segment | revenue | 2022-09-01 → 2023-02-28 | ¥2.8bn |
| jpcrp040300-q2r_E01064-000Department Store Businessreportable segment | revenue external | 2022-09-01 → 2023-02-28 | ¥2.8bn |
| jpcrp040300-q2r_E01064-000Department Store Businessreportable segment | segment profit | 2022-09-01 → 2023-02-28 | ¥13m |
| jpcrp040300-q2r_E01064-000Food Service Businessreportable segment | revenue | 2022-09-01 → 2023-02-28 | ¥698m |
| jpcrp040300-q2r_E01064-000Food Service Businessreportable segment | revenue external | 2022-09-01 → 2023-02-28 | ¥698m |
| jpcrp040300-q2r_E01064-000Food Service Businessreportable segment | segment profit | 2022-09-01 → 2023-02-28 | −¥121m |
| jpcrp040300-q2r_E01064-000Health Carereportable segment | revenue | 2022-09-01 → 2023-02-28 | ¥7.3bn |
| jpcrp040300-q2r_E01064-000Health Carereportable segment | revenue external | 2022-09-01 → 2023-02-28 | ¥7.3bn |
| jpcrp040300-q2r_E01064-000Health Carereportable segment | segment profit | 2022-09-01 → 2023-02-28 | ¥940m |
| jpcrp040300-q2r_E01064-000Medical Productsreportable segment | revenue | 2022-09-01 → 2023-02-28 | ¥1.1bn |
| jpcrp040300-q2r_E01064-000Medical Productsreportable segment | revenue external | 2022-09-01 → 2023-02-28 | ¥1.1bn |
| jpcrp040300-q2r_E01064-000Medical Productsreportable segment | segment profit | 2022-09-01 → 2023-02-28 | ¥103m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-09-01 → 2023-02-28 | ¥12.4bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-09-01 → 2023-02-28 | ¥12.4bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-09-01 → 2023-02-28 | ¥933m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 561
| Item | Context | Value | Unit |
|---|---|---|---|
| Transactions with other segments | Prior1YTDDuration_OtherReportableSegmentsMember | - | JPY |
| Transactions with other segments | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | - | JPY |
| Transactions with other segments | Prior1YTDDuration_ReconcilingItemsMember | - | JPY |
| Transactions with other segments | Prior1YTDDuration | - | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q2r_E01064-000HealthCareReportableSegmentsMember | 7326508000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q2r_E01064-000MedicalProductsReportableSegmentsMember | 1064101000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q2r_E01064-000DepartmentStoreBusinessReportableSegmentMember | 2816517000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q2r_E01064-000FoodServiceBusinessReportableSegmentMember | 697983000 | JPY |
| Net sales | Prior1YTDDuration_OtherReportableSegmentsMember | 539688000 | JPY |
| Net sales | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 12444800000 | JPY |
| Net sales | Prior1YTDDuration_ReconcilingItemsMember | - | JPY |
| Net sales | Prior1YTDDuration | 12444800000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q2r_E01064-000HealthCareReportableSegmentsMember | 940267000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q2r_E01064-000MedicalProductsReportableSegmentsMember | 103468000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q2r_E01064-000DepartmentStoreBusinessReportableSegmentMember | 12788000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q2r_E01064-000FoodServiceBusinessReportableSegmentMember | -121317000 | JPY |
| Operating income | Prior1YTDDuration_OtherReportableSegmentsMember | -1997000 | JPY |
| Operating income | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 933209000 | JPY |
| Operating income | Prior1YTDDuration_ReconcilingItemsMember | -254914000 | JPY |
| Operating income | Prior1YTDDuration | 678295000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q2r_E01064-000HealthCareReportableSegmentsMember | 8785847000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q2r_E01064-000MedicalProductsReportableSegmentsMember | 1083112000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q2r_E01064-000DepartmentStoreBusinessReportableSegmentMember | 2640180000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q2r_E01064-000FoodServiceBusinessReportableSegmentMember | 1032381000 | JPY |
| Revenues from external customers | CurrentYTDDuration_OtherReportableSegmentsMember | 1001459000 | JPY |
| Revenues from external customers | CurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember | 14542980000 | JPY |
| Revenues from external customers | CurrentYTDDuration_ReconcilingItemsMember | - | JPY |
| Revenues from external customers | CurrentYTDDuration | 14542980000 | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q2r_E01064-000HealthCareReportableSegmentsMember | 36282000 | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q2r_E01064-000MedicalProductsReportableSegmentsMember | - | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q2r_E01064-000DepartmentStoreBusinessReportableSegmentMember | 1701000 | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q2r_E01064-000FoodServiceBusinessReportableSegmentMember | 5400000 | JPY |
| Transactions with other segments | CurrentYTDDuration_OtherReportableSegmentsMember | 10242000 | JPY |
| Transactions with other segments | CurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember | 53626000 | JPY |
| Transactions with other segments | CurrentYTDDuration_ReconcilingItemsMember | -53626000 | JPY |
| Transactions with other segments | CurrentYTDDuration | - | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q2r_E01064-000HealthCareReportableSegmentsMember | 8822129000 | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q2r_E01064-000MedicalProductsReportableSegmentsMember | 1083112000 | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q2r_E01064-000DepartmentStoreBusinessReportableSegmentMember | 2641882000 | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q2r_E01064-000FoodServiceBusinessReportableSegmentMember | 1037782000 | JPY |
| Net sales | CurrentYTDDuration_OtherReportableSegmentsMember | 1011701000 | JPY |
| Net sales | CurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember | 14596607000 | JPY |
| Net sales | CurrentYTDDuration_ReconcilingItemsMember | -53626000 | JPY |
| Net sales | CurrentYTDDuration | 14542980000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q2r_E01064-000HealthCareReportableSegmentsMember | 1400009000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q2r_E01064-000MedicalProductsReportableSegmentsMember | 86341000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q2r_E01064-000DepartmentStoreBusinessReportableSegmentMember | 40705000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q2r_E01064-000FoodServiceBusinessReportableSegmentMember | -2090000 | JPY |
| Operating income | CurrentYTDDuration_OtherReportableSegmentsMember | -166748000 | JPY |
| Operating income | CurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember | 1358218000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |